These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29540332)

  • 41. Contrast agents in magnetic resonance imaging.
    Roux E; De Broe L
    J Belge Radiol; 1988; 71(1):31-6. PubMed ID: 3372466
    [No Abstract]   [Full Text] [Related]  

  • 42. Gadolinium-based contrast agents in pediatric magnetic resonance imaging.
    Gale EM; Caravan P; Rao AG; McDonald RJ; Winfeld M; Fleck RJ; Gee MS
    Pediatr Radiol; 2017 May; 47(5):507-521. PubMed ID: 28409250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe adverse reactions with contrast agents for magnetic resonance: clinical experience in 30,000 MR examinations.
    De Ridder F; De Maeseneer M; Stadnik T; Luypaert R; Osteaux M
    JBR-BTR; 2001 Aug; 84(4):150-2. PubMed ID: 11688727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Allergy to radiographic contrast media].
    Vionnet J; Petitpierre S; Fumeaux A; Meuli R; Spertini F; Comte D
    Rev Med Suisse; 2013 Apr; 9(382):812-8. PubMed ID: 23667970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Observed Deposition of Gadolinium in Bone Using a New Noninvasive in Vivo Biomedical Device: Results of a Small Pilot Feasibility Study.
    Lord ML; Chettle DR; Gräfe JL; Noseworthy MD; McNeill FE
    Radiology; 2018 Apr; 287(1):96-103. PubMed ID: 29237148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute side effects of three commonly used gadolinium contrast agents in the paediatric population.
    Neeley C; Moritz M; Brown JJ; Zhou Y
    Br J Radiol; 2016 Jul; 89(1063):20160027. PubMed ID: 27194459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immediate hypersensitivity reaction to gadolinium-based MR contrast media.
    Jung JW; Kang HR; Kim MH; Lee W; Min KU; Han MH; Cho SH
    Radiology; 2012 Aug; 264(2):414-22. PubMed ID: 22550309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gadolinium contrast agent selection and optimal use for body MR imaging.
    Guglielmo FF; Mitchell DG; Gupta S
    Radiol Clin North Am; 2014 Jul; 52(4):637-56. PubMed ID: 24889165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kounis syndrome: simultaneous occurrence of an allergic reaction and myocardial ischemia in a 46 year old patient after administration of contrast agent.
    Zlojtro M; Roginic S; Nikolic-Heitzler V; Babic Z; Kaliterna DM; Marinko A
    Isr Med Assoc J; 2013 Nov; 15(11):725-6. PubMed ID: 24511660
    [No Abstract]   [Full Text] [Related]  

  • 50. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study.
    Brockow K; Romano A; Aberer W; Bircher AJ; Barbaud A; Bonadonna P; Faria E; Kanny G; Lerch M; Pichler WJ; Ring J; Rodrigues Cernadas J; Tomaz E; Demoly P; Christiansen C;
    Allergy; 2009 Feb; 64(2):234-41. PubMed ID: 19178403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of magnetic resonance contrast media.
    Runge VM
    Top Magn Reson Imaging; 2001 Aug; 12(4):309-14. PubMed ID: 11687717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
    Altun E; Martin DR; Wertman R; Lugo-Somolinos A; Fuller ER; Semelka RC
    Radiology; 2009 Dec; 253(3):689-96. PubMed ID: 19789233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contrast Reaction Readiness for Your Department or Facility.
    Wang CL; Soloff EV
    Radiol Clin North Am; 2020 Sep; 58(5):841-850. PubMed ID: 32792118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse reactions to gadolinium contrast media: a review of 36 cases.
    Murphy KJ; Brunberg JA; Cohan RH
    AJR Am J Roentgenol; 1996 Oct; 167(4):847-9. PubMed ID: 8819369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-ionic iodinated contrast media related immediate reactions: A mechanism study of 27 patients.
    Zhai L; Guo X; Zhang H; Jin Q; Zeng Q; Tang X; Gao C
    Leg Med (Tokyo); 2017 Jan; 24():56-62. PubMed ID: 28081790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contrast material-enhanced visualization of the ablation medium for magnetic resonance-monitored ethanol injection therapy: imaging and safety aspects.
    Nanz D; Andreisek G; Fröhlich JM; Weishaupt D; Treiber K; Ess S; Pfammatter T
    J Vasc Interv Radiol; 2006 Jan; 17(1):95-102. PubMed ID: 16415138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of Blood Pool Contrast Agent Administration in Children and Young Adults.
    Rigsby CK; Popescu AR; Nelson P; Orr RJ; Boylan EE; Schoeneman S; deFreitas RA
    AJR Am J Roentgenol; 2015 Nov; 205(5):1114-20. PubMed ID: 26496560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe immediate hypersensitivity to gadolinium contrast agent after targeted treatment in a patient with alveolar soft part sarcoma: A case report and review of literature.
    Yan H; Zhang J; Cai X; Hao Z; Guan Z
    Medicine (Baltimore); 2023 Nov; 102(46):e36092. PubMed ID: 37986295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gadolinium Distribution in Cerebrospinal Fluid after Administration of a Gadolinium-based MR Contrast Agent in Humans.
    Berger F; Kubik-Huch RA; Niemann T; Schmid HR; Poetzsch M; Froehlich JM; Beer JH; Thali MJ; Kraemer T
    Radiology; 2018 Sep; 288(3):703-709. PubMed ID: 29737953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.